Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer
Launched by UNIVERSITY OF UTAH · Jul 28, 2025
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is testing a new way to help men with advanced prostate cancer who live in rural areas stay active and improve their quality of life. Because treatments like hormone therapy (called androgen deprivation therapy or ADT) and surgery can cause side effects such as weakness, fatigue, and other physical and emotional challenges, this study is exploring a 12-week program of guided exercises and support delivered remotely through phone or internet. The goal is to see if this remote rehabilitation is easy to use, acceptable to patients, and helps them stick with their exercise plans.
Men who are 18 or older, have been diagnosed with prostate cancer, are currently receiving hormone therapy for either high-risk or advanced cancer, and live in a rural community may be eligible to join. Participants will take part in the program from home, using phone or internet support, which is especially helpful for those who live far from healthcare centers. However, men with certain heart problems, recent bone injuries, or those already doing regular rehab exercises will not be eligible. This study is still preparing to start recruiting participants.
Gender
MALE
Eligibility criteria
- Inclusion Criteria:
- • Age 18 and older
- • Confirmed diagnosis of prostate cancer
- • Men receiving standard-of-care ADT either for high-risk, locally advanced prostate cancer or as a part of multicomponent management of metastatic prostate cancer
- • Residing in a rural community, as indicated by zip code in RUCA areas
- Exclusion Criteria:
- • Unstable angina, uncontrolled hypertension, recent myocardial infarction, pacemakers, painful or unstable bony metastases, or recent skeletal fractures
- • Engaged in a regular exercise rehabilitation program
- • Relocation plans within next 3 months
- • Participating in another clinical trial
- • Have a working telephone line in their home or a cell phone.
About University Of Utah
The University of Utah is a prestigious research institution known for its commitment to advancing medical knowledge and improving patient care through innovative clinical trials. With a robust infrastructure that supports a wide range of biomedical research initiatives, the university leverages its multidisciplinary expertise and state-of-the-art facilities to conduct rigorous clinical studies. By fostering collaboration among researchers, clinicians, and community partners, the University of Utah aims to translate scientific discoveries into effective therapies and interventions, ultimately enhancing health outcomes and contributing to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Salt Lake City, Utah, United States
Patients applied
Trial Officials
Manish Kohli, MD
Principal Investigator
Huntsman Cancer Institute/ University of Utah
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported